dc.identifier.citation | Anggraini, A. D., Waren, A., Situmorang, E., Asputra, H., & Siahaan, S. S. (2014). Faktor--Faktor Yang Berhubungan Dengan Kejadian Hipertensi Pada Pasien Yang Berobat Di Poliklinik Dewasa Puskesmas Bangkinang Periode Januari Sampai Juni 2008. Universitas Riau. Endang, E. (2018). Kajian Penggunaan Antihipertensi dan Potensi Interaksi Obat Pada Pengobatan Pasien Hipertensi Dengan Komplikasi. Jurnal Farmasi Indonesia, 15(2), 148-162. Kaplan, N. (2015). Chapter 8: hypertensive emergencies. Kaplan’s clinical hypertension. 11th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 263. Kemenkes, R. (2014). Pusdatin Hipertensi. Infodatin,(Hipertensi), 1–7. Lenander, C., Elfsson, B., Danielsson, B., Midlöv, P., & Hasselström, J. (2014). Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scandinavian Journal of Primary Health Care, 32(4), 180-186. Mansjoer, A. (2016). Kapita Selekta Kedokteran, Media Aesculapius. Jakarta. FKUI. Muntner, P., Carey, R. M., Gidding, S., Jones, D. W., Taler, S. J., Wright Jr, J. T., & Whelton, P. K. (2018). Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation, 137(2), 109-118. Nurarif, A., & Kusuma, H. (2016). Asuhan Keperawatan Prakktis Edisi Revisi Jilid 1: MediAction. RISKESDES. (2019). Laporan Provinsi Kalimantan Timur 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan (LPB). Setiabudy, R., & Gan, V. (2017). Farmakologi dan terapi. Rianto Setiabudy & Nafrialdi, Eds.)(Sulistia G). jakarta: Departemen Farmakologi dan Terapeutik Fakultas Kedokteran-Universitas Indonesia. Tuloli, T. S., & Pakaya, M. S. (2021). Identifikasi Drug Related Problems (DRPs) Pasien Hipertensi di RS Multazam Kota Gorontalo. Indonesian Journal of Pharmaceutical Education, 1(1), 1-9. Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Delling, F. N. (2020). Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation, 141(9), e139-e596. Wang, Y.-C., Hsieh, T.-C., Chou, C.-L., Wu, J.-L., & Fang, T.-C. (2016). Risks of adverse events following coprescription of statins and calcium channel blockers: a nationwide population-based study. Medicine, 95(2). Whelton, P. K., Carey, R. M., & Aronow, W. S. (2018). ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, Detection, evaluation, and management of high blood pressure in adults: a Report of the American College of Cardiology/American heart Association. Task force on clinical practice guidelines//J. Am. Coll. Cardiol.-2017.-Nov 13., 7(1). WHO. (2018). Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016. WHO. (2019). Hypertension. Kobe: World Health Organization. WHO. (2022). Hypertension (online) https://www.who.int/news-room/fact-sheets/detail/hypertension Widyati. (2019). Praktik Farmasi Klinik Penyakit Hipertensi. In N. Indrawati & S. Pramodawardhani (Eds.), Praktik Farmasi Klinik. Surabaya: Uwais Inspirasi Indonesia. Wiggins, B. S., Saseen, J. J., Page, R. L., Reed, B. N., Sneed, K., Kostis, J. B., Morris, P. B. (2016). Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 134(21), e468-e495. | id_ID |